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Abstract: The most used experimental mouse model of hyponatremia and elevated intracranial pressure (ICP) is 
intraperitoneal injection of water in combination with antidiuretics. This model of water intoxication (WI) results in 
extreme pathological changes and death within 1 h. To improve preclinical studies of the pathophysiology of elevated 
ICP, we characterized diuresis, cardiovascular parameters, blood ionogram and effects of antidiuretics in this model. 
We subsequently developed a new mouse model with mild hyponatremia and sustained increased ICP. To investigate 
the classical protocol (severe WI), C57BL/6mice were anesthetized and received an intraperitoneal injection of 
20% body weight of MilliQ water with or without 0.4 µg·kg−1 desmopressin acetate (dDAVP). Corresponding Sham 
groups were also studied. In the new WI protocol (mild WI), 10% body weight of a solution containing 6.5 mM 
NaHCO3, 1.125 mM KCl and 29.75 mM NaCl was intraperitoneally injected. By severe WI, ICP and mean arterial 
pressure increased until brain stem herniation occurred (23 ± 3 min after injection). The cardiovascular effects 
were accelerated by dDAVP. Severe WI induced a halt to urine production irrespective of the use of dDAVP. 
Following the new mild WI protocol, ICP also increased but was sustained at a pathologically high level without 
inducing herniation. Mean arterial pressure and urine production were not affected during mild WI. In conclusion, 
the new mild WI protocol is a superior experimental model to study the pathophysiological effects of elevated ICP 
induced by water intoxication.
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Introduction
Hyponatremia (HN) (defined as [Na+]<135–136 mm 
in plasma) [47] is the most common electrolytic disorder 
encountered in the clinical practice, with an estimated 
15–30% of hospitalized patients experiencing mild hn 
([Na+]>130 mM) [50], and 7% developing moderate to 
severe HN ([Na+]<126 and 116 mM, respectively) [19]. 
Several epidemiological studies have found an associa-
tion of hn with increased mortality and longer hospi-
talization independently by its severity [5, 7, 17]. a 
crucial pathological factor determining the outcome of 
hn is the development of hyponatremic encephalopa-
thies and brain edema (BE) [54]. the highest risk of 
cerebral sequelae is posed by severe and acute hn (<48 
h) [43], which can induce osmotic brain swelling and 
increased intracranial pressure (icP) leading to brain 
herniation and death [35]. chronic (>48 h) and mild hn 
induces minor brain swelling as the brain is able to com-
pensate for the decreased osmolarity [15] but, neverthe-
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less, it is associated with neurocognitive dysfunctions 
as impaired cognition, alertness, headaches and confu-
sion [16, 36, 37]. hyponatremia-related mortality is 
independent on its severity [7, 17] and mild hn is 
clinically more frequent than severe HN [50].
Very few studies have investigated whether icP is 
elevated in patients with mild but acute hn, which until 
recently has been considered asymptomatic [9, 54]. due 
to the invasive nature of current techniques, icP monitor-
ing is not performed in patients without a clear indication 
of high ICP [34]. animal studies are limited in this regard 
because, with the exception of chronic hn-models of 
syndrome of inappropriate anti-diuretic hormone (Si-
ADH) [13, 53], few animal models have focused on mild 
hn. therefore, due to the lack of appropriate models, it 
is not known if elevated icP contributes to the neuro-
cognitive sequelae of mild hn.
the most common experimental models to study the 
pathophysiology of hn-induced BE and elevated icP 
rely on the application of a large amount of hypo-osmo-
lar fluid to experimental animals, a procedure com-
monly known as water intoxication (WI) [38]. Wi has 
been performed on a wide range of animals: monkeys 
[8], dogs [8, 38, 44], rabbits [2, 10], pigs [32, 33] and 
rodents, both rats [3, 4, 24, 27, 30, 45, 55] and mice [1, 
25, 31, 48, 52, 56, 57]. most Wi models are based on 
the intraperitoneal (iP) injection of large volumes of 
hypo-osmolar fluid (10–40%) [29] and produce severe 
hn characterized by extremely elevated icP (>40 
mmHg) and death [25] within 60 min. the high severity 
decreases the translational value since the clinical range 
initiating treatment of elevated icP is well below 40 
mmHg (ICP>22 mmHg and ICP<30 mmHg) [28, 42]. 
in addition, in current Wi models, severe hn develops 
acutely within min from water injection [56] which fur-
ther narrows the translational relevance of Wi, because 
mild HN is far more clinically prevalent [50]. hence, 
classical Wi models have limited potential to investigate 
the most clinically relevant ranges of elevated icP and 
hn.
in most of the studies, Wi was coupled with antidi-
uretic pre-treatments as arginine vasopressin (aVP) 
[2–4, 10, 12, 51], pitressin [18], or the aVP analogue 
desmopressin acetate (dDAVP) [1, 25, 33, 52, 57]. the 
rationale for the use of aVP or analogue compounds in 
non-SIADH models [53] is to avoid an increased renal 
water excretion as a compensation to the decreased 
plasma osmolarity [18]. however, the few studies mea-
suring urine production in Wi without antidiuretics re-
ported limited renal compensation to the water load [8, 
10] and no study systemically evaluated the effect of 
antidiuretics in the Wi model. thus, it is an open ques-
tion if the use of non-endogenous aVP or analogues 
results in independent side effects on top of WI-induced 
pathology.
Based on these premises, we defined these aims of the 
study:
1) to evaluate if the application of ddaVP has sig-
nificant effects in the classic mouse model of severe WI 
(20% body weight (BW) infusion of distilled water) in 
terms of urine production, cardiovascular and cerebral 
physiology.
2) to establish a new mouse model of Wi with acute-
ly elevated icP and mild hn, and to characterize this 
model in terms of cardiovascular parameters, icP, diure-
sis and plasma composition.
Materials and Methods
Experimental animals
Experiments were conducted following approval from 
the danish animal Experiments inspectorate (Permit: 
2015-15-0201-00509). male c57BL/6 mice (taconic, 
Ejby, denmark) (9–18 weeks old; BW 24–30 g (26.9 ± 
1.9 g) were used in the study. animals were housed at 
the danish neuroscience center (dnc, aarhus Univer-
sity, aarhus, denmark) in group cages (3–5 mice/cage) 
with ad libitum access to water and standard diet (altro-
min 1320) and with a 12h:12h light-dark cycle at 21 ± 
2°c and 45 ± 5% relative humidity.
Experimental protocols
the study design is summarized in table 1. Experi-
mental protocol 1 was designed to characterize the 
physiology of the mild Wi model with respect to severe 
Wi. Four mice underwent severe Wi with ddaVP as 
described below. Seven mice were exposed to mild Wi 
(described below).
Experimental protocol 2 was designed to evaluate the 
effect of dDAVP during severe WI. Four groups of 6 
mice each were randomly assigned in the following 
groups: Wi with ddaVP (Wi+); Wi without ddaVP 
(WI−); Sham with dDAVP (Sh+); Sham without dDAVP 
(Sh−). Severe WI was performed as described below. 
animals in the Wi+ group received 0.4 µg·kg−1 ddaVP 
([1-deamino-Cys, 8-D-Arg]AVP, V1005, Sigma Aldrich, 
St. Louis, mo, USa), dissolved in the sterile water used 
for Wi (volume indicated below). animals in the Sh+ 
group received ddaVP 0.4 µg·kg−1 iP in 100 µl saline. 
Sh− grouped received 100 µl saline vehicle.
Surgical procedures
Surgical anesthesia was induced using 3% Isoflurane 
(iSo, iSo-Vet, 100%, abbott, chicago, iL, USa) carried 
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by a 9:1− mixture of medical air and oxygen (30% FiO2). 
iSo was reduced to 1.5–1.75% for maintenance. after 
induction of anesthesia, mice were moved to a heating 
pad connected via feedback to a rectal thermometer (hB 
101/2, harvard apparatus, cambridge, ma, USa) to 
maintain body temperature at 37 ± 0.5°c. Eye ointment 
was applied to prevent eye dehydration. to maintain 
hydration status, 50 µl of saline solution (0.9% nacl) 
were injected iP every hour prior to Wi initiation.
all surgical procedures were performed under a dis-
section microscope (olympus, Sz-tB1, tokyo, Japan). 
Prior to surgery, 0.02 ml of Lidocaine (d04aB01, 10 
mg·ml−1) were injected subcutaneously into all surgical 
sites. the following surgical procedures were performed 
in both experimental protocols.
a) Bladder catheterization: an abdominal incision (2 
cm) was performed. abdominal muscles were carefully 
trimmed and the bladder exposed. a small incision on 
the bladder was made and the catheter (PE50, inner di-
ameter (id): 0.5 mm, intramedic clay adams, Becton 
dickinson, Franklin Lakes, USa), was carefully in-
serted and secured to the bladder with silk sutures. after 
surgical closure, urine was collected from the catheter 
in 75 µl non-heparinized capillary tubes and diuresis 
measured by recording the length of the liquid column 
in the tube at fixed time points.
b) cannulation of femoral artery: a small incision (1 
cm) was made in the left inguinal region and tissue was 
dissected until the vessels were visible. the artery was 
dissected from femoral vein and nerve and transiently 
clamped before catheter insertion to prevent back-flow. 
A catheter (PE10, id: 0.28 mm) filled with 5% heparin-
ized saline (heparin LEo, 100 U·ml−1, Leo Pharma, 
Ballerup, denmark) was advanced towards abdominal 
aorta. the catheter was secured to the skin by silk sutures 
during surgical closure.
c) tracheostomy: a PE90 catheter (id: 0.8 mm) was 
inserted in the trachea and immediately connected to 
artificial ventilation apparatus (SAR-830/P, CWE Inc., 
ardmore, Pa, USa). iSo administration was continued 
through tracheal tube.
in experimental protocol 1, an additional surgical 
procedure was performed to measure icP. the head of 
the mouse was shaved and the left frontal bone was se-
cured to a custom-made head frame with dental cement 
(Gc Fuji PLUS, Gc Europe, Leuven, Belgium). a cir-
cular area of ~3 mm in diameter between temporal and 
parietal muscle was drilled at 1,000 round per min 
(rPm) until intact dura was visible. an icP transducer 
(codman microsensor, dePuy Synthes, Warsaw, in, 
USa) was inserted between the skull and dura. the sen-
sor was fixed to the skull with biocompatible, temporary 
dental cement (Speiko, münster, Germany).
Physiological monitoring
Physiological data were digitally collected using a 
PowerLab 8/35 data acquisition device and Labchart 
acquisition software (adinstruments Ltd., oxford, UK). 
End-tidal pco2 (Etco2) was monitored by a capnograph 
(microcapStar End-tidal co2 analyser, cWE inc.). 
Table 1. Schematic summary of experimental protocols, animals groups, surgical procedures and data collected in this study
Groups Surgery timeline data
Protocol 1 Severe Wi (n=4)  
[20 % BW − MilliQ water] 
mild Wi (n=7)  
[10% BW − 36.25 mM Na+] 
Bladder catheter 
artery catheter  
(femoral artery)
tracheostomy  
(mechanical ventilation) 
icP-probe insertion
1. Isoflurane: 3% induction  
1.5–1.75% maintainance
maP (and hr)
icP
CPP = MAP − ICP
Urine production
arterial blood gases and ions
2. Surgerical procedures
3. time: -40–0 min.  
Baseline recording
4. time: 0 min.  
Wi induction
5. time: 0–60/90 min.  
Wi recording 
Protocol 2 Severe Wi + ddaVP (n=6) 
Severe WI − dDAVP (n=6) 
Sham + ddaVP (n=6) 
Sham − dDAVP (n=6)
Bladder catheter 
artery catheter  
(femoral artery) 
tracheostomy  
(mechanical ventilation) 
1. Isoflurane: 3% induction  
1.5–1.75% maintainance
maP (and hr)
Urine production
arterial blood gases and ions
2. Surgerical procedures
3. time: -40–0 min.  
Baseline recording
4. time: 0 min.  
Wi induction
5. time: 0–60 min.  
Wi recording 
Wi, water intoxication; BW, body weight; ddaVP, desmopressin acetate; maP, mean arterial pressure; hr, heart rate; icP, intracranial 
pressure; cPP, cerebral perfusion pressure.
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after synchronization, ventilation parameters were ad-
justed to maintain Etco2 in a range between 35–45 
mmhg. Ventilation parameters were based on manufac-
turer instruction and previous studies [40].
mean arterial pressure (maP) and heart rate (hr) 
were monitored by a pressure transducer (BLPr2, WPi 
inc., Sarasota, FL, USa) connected to the arterial cath-
eter. arterial ph, pco2, po2, [Na+], [K+], [Cl−], [HCO3−], 
oxygen saturation of hemoglobin (so2) and hemoglobin 
concentration (cthb) were examined on a blood gas 
analyzer (aBL90FLEX, radiometer, copenhagen, den-
mark) on 70 µl blood samples.
the prolonged use of inhalation anaesthetics can in-
duce severe respiratory suppression [49], acidosis [20], 
dose-dependent hypotension [14] and a higher perme-
ability of blood brain barrier [46] in experimental mice. 
to minimize the interference of anaesthesia on the results 
from experimental animals, we defined exclusion crite-
ria at baseline. Wi was performed only if the monitored 
physiological parameters were within the following 
limits: ph (7.35–7.45) and pco2 (30–40 mm Hg) [20]; 
(so2>96%) [49]; MAP>70 mmHg [58]; icP<20 mmhg; 
[Na+] between 135–150 mm. if the measurements felt 
outside these ranges, the ventilation parameters were 
modified and 50 µl physiological saline was given before 
an additional arterial blood-sample was analyzed 10 min 
after intervention. adjustments could be repeated up to 
a maximum of 3 times before Wi and, if not successful, 
mice were sacrificed by cervical dislocation and ex-
cluded from the data set.
Water intoxication procedures
two procedures of water intoxication by iP injection 
were used. Severe WI: the infused solution was 20% 
BW of MilliQ water (4.8–6 ml) with 0.4 µg·kg−1 ddaVP 
as used in previous studies [25]. Mild WI: Based on a 
small number of pilot-studies, the composition of the 
infused solution was defined as: NaHCO3: 6.5 mm; Kcl: 
1.125 mm; and nacl: 29.75 mm, giving a total concen-
tration of [Na+] of 36.25 mm. injection volume of the 
mild-Wi solution was 10% BW (2.5–3 ml).
For both severe Wi and mild Wi the protocol con-
sisted of: 1) a period of baseline monitoring (40 min); 
2) 2 min of iP infusion of 37°c Wi solution using an 
automatic infusion pump (Genietouch Syringe pump, 
Kent Scientific Corp., Torrington, CT, USA); 3) a post-
infusion period of Wi monitoring. mice were monitored 
for a maximum of 1 h after severe Wi and 90 min after 
mild WI and then sacrificed by cervical dislocation.
Statistical analysis
Graphical representation and statistical analyses were 
performed on GraphPad Prism version 7.0 (GraphPad 
Software, La Jolla, CA, USA). Significance (P-val-
ue<0.05 (α=5%)) is indicated by the exact P-value or 
given as follows: *:P<0.05; **:P<0.01; ***:P<0.001. 
Gaussian distribution and equality of variance were 
checked before each test. anoVa was followed by 
Fisher’s LSd post-hoc test (no correction for multiple 
comparisons). anoVa with matching values and paired 
t-tests were used for the comparison of animals with their 
respective baseline. Unpaired t-test was used for com-
parisons of severe and mild Wi protocols. data are re-
ported as mean ± SEM, unless specified elsewhere.
Results
ICP increases and peaks within 30 min in the severe 
WI model
In severe WI, a significant increase of ICP from base-
line was detected at 7.5 ± 2.1 min after initiation of Wi. 
icP then dramatically increased from a mean baseline 
value of 8.49 ± 3.34 mmhg to a mean peak value of 84.7 
± 3.0 mmhg (P=0.0002), which occurred at 23.0 ± 2.9 
min after initiation of Wi (Fig. 1a). after the maX peak, 
icP rapidly dropped to a minimum mean value of 29.9 
± 6.2 mmhg.
as a consequence of the increase in icP and despite 
counteracting changes in maP (Fig. 1b), the cerebral 
perfusion pressure (CPP = MAP − ICP) gradually de-
clined during the experiment (Fig. 1c). at baseline cPP 
was 70.9 ± 1.74 mmHg, but after 8 min a significant fall 
was detected (63 ± 6.2 mmHg) in parallel to the first 
significant increase of ICP (7.5 min). After the ICP peak, 
cPP was 22.4 ± 1.04 mmhg (68% decrease, P=0.00057 
vs. baseline) and continued to fall until 32.0 ± 2.0 min 
after Wi, when maP and icP were approximately equal 
(cPP = 0.9 ± 2.0 mmhg, P=0.00003 vs. baseline).
Severe Wi animals developed arterial hypertension 
(Fig. 1b) in response to increased icP and showed un-
stable hr in the time interval 20–35 min where the high-
est values of icP and maP were recorded (Fig. 1d).
Values of Etco2 were maintained in physiological 
ranges by mechanical ventilation to avoid respiratory 
acidosis (Fig. 1e). However, even with artificial ventila-
tion, an irregular pattern of Etco2 peaks was observed 
at baseline, probably caused by occasional spontaneous 
breathing. the pattern of Etco2 peaks became more 
regular ~25 min after initiation of Wi. if ventilation was 
discontinued, the mice undergoing severe Wi died.
Mild WI induced a moderate and sustained increase 
in ICP
Following induction of mild WI, the first significant 
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increase in icP from baseline was detected at 5.75 ± 0.5 
min from Wi initiation (icP was 2.0 ± 1.0 mmhg high-
er than baseline, P=0.037) (Fig. 2a). icP increased af-
terwards and 19 min after Wi all animals experienced 
cranial hypertension (icP>20 mmhg). the increasing 
trend of icP stopped at 40 min from Wi initiation, where 
icP was 36.1 ± 1.2 mmhg. Between 40 to 60 min from 
Wi (36.1 ± 1.2 vs. 41.0 ± 1.1 mmhg, respectively) the 
data points were statistically indistinguishable (P=0.956, 
one-way matched ANOVA). ICP was not different be-
tween 40 and 90 min after Wi initiation (36.1 ± 1.2 
mmhg vs. 33.7 ± 6.3 mmhg respectively, P=0.52). a 
single mouse showed a drop in icP at 72 min from Wi. 
maP slightly increased from Wi initiation (68.8 ± 1.3 
mmhg) to 60 min after Wi (76.3 ± 1.8 mmhg) (Fig. 2b), 
but no significant hypertensive peak was observed. The 
continuous increase in icP and almost constant maP 
resulted in a decrease in CPP (Fig. 2c). The first signifi-
cant decrease in cPP from baseline (59.45 ± 1.35 mmhg) 
was detected at 24 min (45.91 ± 2.0 mmhg, P=0.046). 
at 60 min cPP had declined to pathological levels (35.2 
± 8.9 mmhg, 40% drop from baseline, P<0.001).
after an initial increase, hr was fairly stable 20 min 
after induction of mild Wi (Fig. 2d). the ventilation 
pattern was slightly irregular for the whole experimental 
time after mild Wi (Fig. 2e) and animals did not im-
mediately die when artificial ventilation was temporar-
ily discontinued (data not shown).
a direct comparison shows the increase in icP in mice 
undergoing mild WI to be significantly less dramatic 
than in severe Wi (Fig. 3a) (area under the curve (aUc): 
2,481 ± 66.5 and 1731 ± 45.1 for severe Wi and mild 
Wi respectively, P<0.001). CPP was significantly more 
preserved and never completely abolished after mild Wi 
(aUc: 1,330 ± 36.5 and 2,711 ± 72.2 for severe Wi and 
mild Wi respectively, P<0.001) (Fig. 3b).
Fig. 1. time-course of intracranial pressure (icP), mean arterial 
pressure (maP), cerebral perfusion pressure (cPP) and 
heart rate (hr) during severe water intoxication (Wi). a, 
ICP; b, MAP; ϴ, animal death; c, CPP; d, HR; e, end-
tidal pco2 (Etco2) period (peaks/s). mean ± SEm (n=4). 
*: first significant deviation from baseline. Time (0): Wi 
initiation. maX time of recorded icP maximum value. 
data from animals dying before the end of experiment 
were omitted after death. data from experimental protocol 
1. Sampling: during baseline: mean of 12 s every 2 min; 
after Wi, mean of 5 s every 2 min.
Fig. 2. time-course of intracranial pressure (icP), mean arterial 
pressure (maP), cerebral perfusion pressure (cPP) and 
heart rate (hr) during mild water intoxication (Wi). a, 
ICP; b, MAP; ϴ, animal death; c, CPP; d, HR; e, end-
tidal pco2 (Etco2) period (peaks/s). mean ± SEm (n=4). 
*: first significant deviation from baseline. Time(0): Wi 
initiation. data from animals dying before the end of ex-
periment were omitted after death. data from experimen-
tal protocol 1. Sampling: during baseline: mean of 12 s 
every 2 min; after Wi, mean of 5 s every 2 min.
MODEL OF HIGH ICP AND MILD HYPONATREMIA
97|Exp. Anim. 2020; 69(1): 92–103
dDAVP accentuates changes in MAP and HR during 
severe WI
Similarly to Experimental protocol 1 also animals 
exposed to severe Wi in Experimental protocol 2 expe-
rienced an increased maP and hr after Wi (Figs. 4a 
and c). the hypertensive peak (maX, Fig. 4a) was re-
corded both in Wi- (112.7 ± 24.4 mmhg, net increase: 
39 ± 22.7 mmhg, P=0.019), and Wi + (125.6 ± 21.5 
mmhg, net increase: 52.4 ± 24 mmhg, P=0.008). the 
MAX peak occurred significantly earlier in the WI+ 
group (Wi-: 25.5 ± 2.0 min, Wi+: 22.6 ± 2.5 min, 
P=0.0339) (Fig. 4b). Shortly after the peak, maP de-
creased to levels significantly below baseline in both 
groups (WI−: 36.0 ± 8.8 mmHg, WI+: 31.2 ± 12.5 
mmhg) (net decrease: 38.0 ± 10.0 and 42.0 ± 12.0 mmhg 
for WI− and WI+ respectively, P=0.0013 and P=0.0016 
vs. baseline) and significant hypotension was observed 
from ~30 min after Wi initiation until the end of the 
experiment (mean maP between 30–60 min after Wi: 
40.8 ± 11.8 in WI−, 35.9 ± 9.8 in WI+, P=0.01 and 
P=0.0007 vs. baseline, respectively).
a tendency towards increased hr was evident in both 
WI− and WI+ groups after induction of WI. Maximum 
hr was seen between 20 and 30 min after induction of 
Wi (Fig. 4c). this time interval coincides with the maX 
value of maP. in this 10 min time interval, the mean hr 
was significantly higher in WI+ compared to WI− 
(P=0.0328) (Fig. 4d).
Urine flow rate is drastically reduced by severe WI 
irrespective of the administration of dDAVP
In Protocol 2, urine flow rate was similar at baseline 
in all groups but WI+, WI− and Sh+ groups showed 
significantly lower urine flow rates after WI (P<0.001 
in all 3 groups) (Fig. 5). administration of ddaVP in-
duced a significantly lower urine flow rate in Sh+ animals 
compared to Sh− (P=0.0323), but dDAVP had no effect 
in Wi groups since both experienced a dramatic reduc-
tion in urine production after severe Wi.
In Protocol 1, urine flow rate was stable after mild WI 
and not significantly different between baseline period 
and Wi (0.030 ± 0.005 vs. 0.028 ± 0.006 µl*min−1*g 
BW−1, P=0.779) (Fig. 5).
Mild WI results in sustained mild hyponatremia
Following mild WI, a significant drop in [Na+] oc-
curred in the first blood samples obtained after WI ini-
tiation (baseline: 149.2 ± 0.62 mm; 14.5 min: 136 ± 0.57 
mm, P<0.001) (Fig. 6a), but [Na+] was subsequently 
stable and mild hn was evident until the end of the 
experiment (133.8 ± 1.2, 133.5 ± 0.7, 135.8 ± 1.3 mm 
at 29, 50 and 90 min from Wi, respectively). on the 
other hand, in severe WI mice, mild but significant HN 
(WI−: 130 ± 1.0 mM, WI+: 128 ± 0.28) developed 
within 5 min and became moderate-to-severe hn after 
20 min from initiation of WI (WI−: 107.8 ± 0.9 mM, 
Wi+: 107.6 ± 0.7 at 35 min), irrespectively of the use of 
ddaVP. no further changes were observed at 60 min 
(WI−: 103.0 ± 2.3, WI+: 105.5 ± 1.23).
Plasma [Cl−] showed a similar pattern as [Na+] in both 
severe and mild WI (Fig. 6b). Plasma [K+] did not 
change, except in the late phases of severe Wi where 
hyperkalemia was observed (Fig. 6c).
Severe, but not mild WI, induces rapid dilutional 
acidosis
During severe WI, a significant drop in blood pH was 
observed in WI groups already at 5 min (ΔpH = −0.083 
± 0.04, −0.095 ± 0.04 for WI− and +, respectively) 
(table 2). Acidosis worsened after 35 min (ΔpH = −0.25 
Fig. 3. comparison of the intracranial pressure (icP) and cerebral 
perfusion pressure (cPP) during severe and mild water 
intoxication (Wi). a, icP; b, cPP. mean ± SEm (n=4). 
Severe Wi (black circle, dotted line) and mild Wi (black 
square, solid line). data from experimental protocol 1. 
Statistical comparison: unpaired t-test of the area under 
the curve (aUc) of the trace for each parameter.
L. BORDONI, ET AL.
98 | doi: 10.1538/expanim.19-0040
and −0.28 from baseline for WI+ and −, respectively). 
decreases in bicarbonate were found in both Wi+ and 
WI− groups (ΔHCO3− = −7.0 and −6.6 mM after 35 min, 
respectively) (table 2).
In mild WI, both pH and [HCO3−] were higher than 
in severe Wi at similar time points (P=0.0149) (Figs. 6d 
and e) and acidosis occurred late in the experimental 
period (50 ± 4.5 min from Wi). the late acidosis in mild 
WI animals had a respiratory origin, since [HCO3−] did 
not decrease in that time period (Fig. 6e) while pco2 
Fig. 4. Effects of desmopressin acetate (dDAVP) on MAP and heart rate (HR) during severe water intoxication 
(Wi). a, raw maP trace showing the development of acute hypertension. maX indicates maximum 
MAP recorded; b, Effect of dDAVP on time to MAX from WI initiation. Mean ± SEM (n=5), unpaired 
t-test; c, representative hr trace. d, averaged hr between t(20) and t(30) after Wi of each mouse. mean 
± SEm (n=5), unpaired t-test. data from experimental protocol 2.
Fig. 5. Mean urine flow rate during baseline and water intoxication (WI) periods. 
Light Grey, Baseline; dark Grey, Wi. mean ± SEm (n=6). Statistical com-
parisons: paired two-way anoVa with Fisher’s LdS post hoc test and unpaired 
t-test between WI of different groups. Data from both Experimental protocols.
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increased, although not significantly (baseline: 33.2 ± 
2.87 mmhg; 50 min: 43.7 ± 7.3 mmhg, P=0.107; 90 
min: 47 ± 5.9 mmhg, P=0.0385).
Hemoglobin concentration is unchanged by severe 
WI but reduced by mild WI
Hemoglobin concentration (ctHb) was not signifi-
cantly affected by severe WI or application of dDAVP 
Fig. 6. Plasma ionogram and acid/base status (ph, and bicarbonate) and concentration of hemoglobin. a, sodium; b, chloride; c, 
potassium; d, ph; e, bicarbonate; f, hemoglobin concentration (cthb). Statistical comparisons: paired one-way anoVa with 
Fisher’s LDS post hoc test (Different time points within the same group). Mean ± SEM (n=5). Data from both Experimen-
tal protocols (p1: protocol 1). Differences between the second time point (29 ± 4.4 min) of mild and severe water intoxica-
tion (Wi) of Experimental protocol 1 were evaluated with unpaired t-test. clinical thresholds for mild (mihn), moderate 
(mohn) and severe hyponatremia (Sehn), hyperkalemia (hyK) and acidosis are indicated by dotted horizontal lines.
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(Table 2 and Fig. 6f). Interestingly, a small, yet signifi-
cant fall in cthb was seen in the late phase of the mild 
Wi experimental group (Fig. 6f).
Discussion
The time course of ICP during severe WI reflects a 
rapid accumulation of intracranial water due to hypona-
tremia/hyposmolarity followed by herniation. despite 
concomitant increase in maP during Wi, cPP is ex-
tremely low 30 min after initiation of Wi, and the mouse 
is only alive due to artificial ventilation. dDAVP induced 
no changes in the overall outcome, but slightly affected 
the time-course of changes in maP, icP and hr. Surpris-
ingly, urine production was abruptly halted after severe 
WI even without administration of dDAVP. This finding 
is consistent with the sparse data in the literature on urine 
production during WI-induced BE [8, 10], but contrasts 
the assumption underlying the general use of ddaVP in 
this model: to block renal adaptation. despite the abun-
dant use of the model, the pathophysiology of the severe 
Wi model is not fully understood, especially with respect 
to renal and cardiovascular changes.
the model of mild Wi also showed the aimed patho-
physiological changes (mild hyponatremia and elevated 
icP), but did not show the complete respiratory depres-
sion, which was seen in all animals undergoing severe 
Wi between 20 and 25 min from Wi, and which is a sign 
of permanent damage in the respiratory center in the 
medulla oblongata [35]. Such damage can also result in 
an increased MAP [6], which was simultaneously ob-
served prior to Etco2 peak homogenization in severe 
Wi. mild Wi also did not result in abrupt halt of urine 
production, and as the mild Wi model did not involve 
use of dDAVP, unwanted side effects from this drug are 
also avoided. the mild Wi model may thus allow studies 
of renal compensation to sustained elevated icP and 
sudden changes in brain osmolarity, such as changes in 
ion excretion or the osmopressor response [26]. Lastly, 
mild Wi induced only acute and mild hyponatremia, 
which has been far less studied in animal models and, 
in its chronic manifestation, is associated with symptoms 
of neurocognitive and neurovascular impairments [9, 36, 
37].
Injection of dDAVP affects cardiovascular 
parameters during severe WI
With ddaVP, herniation occurred slightly, but sig-
nificantly, earlier, and the severe WI group treated with 
dDAVP had significantly higher HR when herniating. 
Since dDAVP had no effect on diuresis, the cardiovas-
cular changes induced by ddaVP must be ascribed to 
other mechanisms than inhibition of renal water excre-
tion.
The cardiovascular effects of dDAVP may be medi-
ated by V1b-receptors, which ddaVP is known to acti-
vate besides their pharmacological main target: V2-re-
ceptors [39]. V1b-receptors are (among other places) 
found in the anterior pituitary, where they influence 
ACTH release, and in chromaffin cells of the adrenal 
Table 2. arterial acid/base status in severe water intoxication (Wi)
Phase Baseline Experimental Experimental Experiment end
time 0 5 35 60
ph WI− 7.43 ± 0.04 7.35 ± 0.05** 7.18 ± 0.07** 7.2 ± 0.04**
Wi+ 7.44 ± 0.04 7.34 ± 0.03* 7.15 ± 0.03*** 7.06 ± 0.01**
Sh− 7.41 ± 0.03 7.4 ± 0.04 7.42 ± 0.05 7.36 ± 0.11
Sh+ 7.43 ± 0.01 7.43 ± 0.02 7.43 ± 0.03 7.44 ± 0.04
pco2 (mmhg) WI− 30 ± 1.3 30 ± 1.4 37 ± 2* 36 ± 3.1
Wi+ 31 ± 2.7 34 ± 1.4 44 ± 3.9** 51 ± 6***
Sh− 33 ± 1.1 34 ± 1.1 31 ± 1.5 33 ± 2.5
Sh+ 34 ± 1.5 33 ± 1.1 31 ± 0.5 30 ± 1.3
hco3− (mm) WI− 20.7 ± 0.6 17.2 ± 0.7*** 14.1 ± 0.3*** 12.4 ± 0.6***
Wi+ 21.6 ± 0.9 18.8 ± 0.5** 14.6 ± 0.4*** 13.3 ± 0.9***
Sh− 21.6 ± 0.5 22 ± 0.5 21 ± 0.6 19.4 ± 0.7
Sh+ 23.3 ± 0.7 22.5 ± 0.9 21.5 ± 0.6 21.4 ± 0.4
cthb (g/dL) WI− 13.84 ± 0.25 13.74 ± 0.38 13.34 ± 0.42 13.3 ± 0.44
Wi+ 13.32 ± 0.23 13.1 ± 0.18 12.56 ± 0.18 12.4 ± 0.28
Sh− 13.8 ± 0.13 14.13 ± 0.12 13.93 ± 0.3 13.05 ± 0.25
Sh+ 13.14 ± 0.59 13.32 ± 0.45 13.5 ± 0.35 13.3 ± 0.3
arterial blood acid/base status (ph, pco2, bicarbonate), and concentration of hemoglobin (ct[Hb]) in 
Experimental protocol 2. mean ± SEm (n=5). Statistical comparisons: paired one-way anoVa within 
the same group followed by Fisher’s LdS multiple comparisons against baseline (time=0). *P<0.05, 
**P<0.01, ***P<0.001.
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medulla, where they may control release of catechol-
amines, which in turn would stimulate hr and maP 
[23]. Since the affinity of dDAVP towards V2-receptors 
is about 4-fold that of AVP [41] ddaVP may also induce 
its effect on cardiovascular parameters by displacement 
of aVP from V2-receptors. in turn, displaced aVP could 
activate vascular V1a receptors.
in conclusion, the results do not support the use of 
ddaVP in the animal model of BE induced by Wi, since 
significant effects of the drug are observed in cardiovas-
cular parameters rather than in reduction of urine produc-
tion, which has been the main rationale for the use of 
dDAVP in previous studies [18]. this being said, endog-
enous AVP may likely play a role during BE [22]. a 
recent systematic review demonstrated not only that 
elevated icP induces release of adh, but also that this 
triggering mechanism can override the effect of plasma 
osmolarity on ADH [21]. therefore, release of adh can 
be promoted even in situation of plasma dilution if the 
brain effective circulatory volume is reduced of more 
than 5–10% [6] due to increased icP. in the Wi models 
explored in this study, adh secretion and the consequent 
paradoxical reduction in renal water excretion could thus 
be seen as part of a physiological response to increase 
cPP by vasoconstriction resulting in increased maP.
Severe WI induces hypo- or euvolemic HN, while 
mild WI induces sign of hypervolemia
In severe WI, the main ions in plasma ([Na+] and 
[Cl−]) are diluted either due to expansion of plasma and 
EcF volume after Wi (hypervolemic hn) or loss of ions 
from plasma circulation into the injected water in the 
abdominal cavity or by a combination of these two 
mechanisms.
In the first and third cases, ctHb would be reduced, 
whereas in the second case cthb would be unchanged. 
in severe Wi, no change in cthb was seen in both pro-
tocols. as urine was not produced, we can exclude a 
renal mechanism influencing plasma ion composition, 
so net movement of ions into the hypo-osmolar abdom-
inal fluid seems the dominating process leading to hypo-
osmolality in the severe Wi model. a study in pigs also 
found Wi to induce hypovolemic hn by ion redistribu-
tion from ECF into the peritoneal fluid [32]. in conclu-
sion, the severe Wi procedure in mice induces euvolemic, 
or possibly hypovolemic hn.
the reductions in plasma ion concentrations were 
much smaller in mild Wi than in severe Wi. mild Wi 
animals showed a decrease in cthb after 50 min, which 
indicates plasma volume expansion. net movement of 
water from the injected solution to the blood thus takes 
place, although some ions probably also leaves plasma 
towards the IP fluid. As diuresis is unchanged, the water 
load may thus be gradually excreted by the kidneys as 
it enters the blood. the pathophysiological mechanisms 
for the apparent inability of water to pass the peritoneal 
membrane if injected as distilled water are unclear.
Mild WI is a new model with mild HN and sustained 
elevated ICP
mild Wi animals experienced a persistent state of mild 
hn throughout the whole experiment (until 90 min from 
Wi) and a persistent elevated icP (higher than 20 
mmHg). The first time point in which ICP increased from 
baseline was not different from the severe WI model, but 
both the rate and the magnitude of the increase in icP 
were lower following mild Wi (~10-fold increase in 20 
min in severe Wi vs. ~6-fold increase in 40 min in mild 
WI). ICP fluctuated between 20–40 mmHg for most of 
the experimental period without a concomitant increase 
in maP. as a result, cPP was stable around 60 mmhg 
for the first 20 min from WI, but afterwards gradually 
dropped to 40–45 mmhg, which in adult tBi patients is 
considered an indicator of potential cerebral ischemia 
[35]. the new model of mild Wi thus enables studies in 
the mouse of the clinically relevant pathophysiology of 
elevated icP and reduced cPP in the absence of side 
effects (loss of spontaneous respiration, drastic increase 
in maP, decreased urine production, hyperkalemia) 
generated by the severe Wi model.
the mild Wi mouse model is therefore more useful to 
characterize the effect of persistently elevated ICP and 
the efficacy of ICP-reducing agents. The short duration 
of the severe model hampers the use of hard endpoints 
(e.g. survival) in studies of pharmacological intervention 
of elevated icP, since the mice may die even before the 
test substances are cleared from circulation [11]. in fu-
ture investigations, the mouse model of mild Wi could 
be used for even longer studies than 90 min and may 
even, as the severe model has been [25], be performed 
without anesthesia to quantify neurological functionality 
and vascular cerebral effects during elevations of ICP. 
due to the absence of good treatments, mild elevation 
of icP is clinically often treated conservatively. the mild 
Wi mouse model can be used to investigate new treat-
ment options for this patient group.
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